Bisdichloroacetyldiamines
Alternative Name: BDADs
Description: Bisdichloroacetyldiamines (BDADs, e.g. WIN 18,446) were shown to inhibit testicular retinoic acid biosynthesis and complete arrest of spermatogenesis.
Product Details
User: ,
Regimen:
Active Pharmaceutical Ingredient (API):
Status Details
Developer: ,
Began discovery in: 2008
Status Details: - Known to cause unpleasant disulfirim reactions when administered with alcohol due to inhibition of ALDH2 (involved in alcohol metabolism in liver), so further development was abandoned.
- In females, WIN 18,446 treatment significantly reduced fecundity, but the compound’s disruption of fetal development makes its appeal as a contraceptive limited.
- Known to cause unpleasant disulfirim reactions when administered with alcohol due to inhibition of ALDH2 (involved in alcohol metabolism in liver), so further development was abandoned.
- In females, WIN 18,446 treatment significantly reduced fecundity, but the compound’s disruption of fetal development makes its appeal as a contraceptive limited.
Additional Information
References: Paik J, et al. (2018). Can inhibition of retinoic acid biosynthesis function as a non-hormonal female contraceptive? Contraception, 98(2), 141-143.
Beyler, A., et al. (1961). The selective testicular effects of certain bis-(dichloroacetyl) diamines. Endocrinology, 69(4), 819-833.
Paik J, et al. (2018). Can inhibition of retinoic acid biosynthesis function as a non-hormonal female contraceptive? Contraception, 98(2), 141-143.
Beyler, A., et al. (1961). The selective testicular effects of certain bis-(dichloroacetyl) diamines. Endocrinology, 69(4), 819-833.
Footnotes: - See also ALDH1A2 Inhibitors.
- See also ALDH1A2 Inhibitors.